Page last updated: 2024-11-07

prednisone and Cutaneous Mastocytosis

prednisone has been researched along with Cutaneous Mastocytosis in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weishaar, KM1
Ehrhart, EJ1
Avery, AC1
Charles, JB1
Elmslie, RE1
Vail, DM1
London, CA1
Clifford, CA1
Eickhoff, JC1
Thamm, DH2
Webster, JD1
Yuzbasiyan-Gurkan, V1
Hamilton, E1
Kiupel, M1

Trials

1 trial available for prednisone and Cutaneous Mastocytosis

ArticleYear
c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.
    Journal of veterinary internal medicine, 2018, Volume: 32, Issue:1

    Topics: Animals; Antineoplastic Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Indoles; Male; Ma

2018

Other Studies

1 other study available for prednisone and Cutaneous Mastocytosis

ArticleYear
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
    BMC veterinary research, 2008, Aug-13, Volume: 4

    Topics: Animals; Dog Diseases; Dogs; Gene Duplication; Kaplan-Meier Estimate; Male; Mastocytosis, Cutaneous;

2008